“…Digitoxin consists of digitoxigenin (pharmacophore) and the trisaccharide moiety, which are known to play a crucial role in both its cardiotoxicity and anticancer activity . Because digitoxin’s cardiotonic activity has been known for a much longer time, most structure activity relationship (SAR) studies have focused on the Na + /K + ATPase inhibition and examined the effect of modifying the carbohydrate portion of the cardiac glycosides. − More recently, Karlish demonstrated that inhibition of the α2-isoform over the α1-Na + /K + ATPase isoform could induce cardiac contraction with minimal Ca 2+ overload and less cardiotoxicity. , These studies also suggest that an α2-selective cardiac glycoside could result from sugar modification, as the structural differences in these isoforms lie primarily in the extracellular carbohydrate binding loops. Thus, sugar modification could provide the potential for the discovery of new and safer digitoxin analogues with improved anticancer activity.…”